These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23856332)

  • 1. Vaccine effects and impact of vaccination programmes in post-licensure studies.
    Hanquet G; Valenciano M; Simondon F; Moren A
    Vaccine; 2013 Nov; 31(48):5634-42. PubMed ID: 23856332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of indirect benefits of vaccination on postlicensure vaccine effectiveness estimates: A scenario analysis.
    Patel MM; Tate J; Cortese M; Payne DC; Armstrong G; Parashar UD; Lopman B
    Vaccine; 2010 Nov; 28(50):7987-92. PubMed ID: 20875493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational methods in epidemiologic assessment of vaccine effectiveness.
    Torvaldsen S; McIntyre PB
    Commun Dis Intell Q Rep; 2002; 26(3):451-7. PubMed ID: 12416713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical considerations in post-market-approval monitoring and regulation of vaccines.
    Thompson A; Komparic A; Smith MJ
    Vaccine; 2014 Dec; 32(52):7171-4. PubMed ID: 25454882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-licensure monitoring of HPV vaccine in the United States.
    Markowitz LE; Hariri S; Unger ER; Saraiya M; Datta SD; Dunne EF
    Vaccine; 2010 Jul; 28(30):4731-7. PubMed ID: 20188681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The public health value of vaccines beyond efficacy: methods, measures and outcomes.
    Wilder-Smith A; Longini I; Zuber PL; Bärnighausen T; Edmunds WJ; Dean N; Spicher VM; Benissa MR; Gessner BD
    BMC Med; 2017 Jul; 15(1):138. PubMed ID: 28743299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe.
    Bonhoeffer J; Black S; Izurieta H; Zuber P; Sturkenboom M
    Biologicals; 2012 Sep; 40(5):393-7. PubMed ID: 22902972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 5-year Chlamydia vaccination programme could reverse disease-related koala population decline: predictions from a mathematical model using field data.
    Craig AP; Hanger J; Loader J; Ellis WA; Callaghan J; Dexter C; Jones D; Beagley KW; Timms P; Wilson DP
    Vaccine; 2014 Jul; 32(33):4163-70. PubMed ID: 24877768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.
    Rozenbaum MH; Sanders EA; van Hoek AJ; Jansen AG; van der Ende A; van den Dobbelsteen G; Rodenburg GD; Hak E; Postma MJ
    BMJ; 2010 Jun; 340():c2509. PubMed ID: 20519267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basis for vaccine recommendations].
    Lévy-Bruhl D
    Med Sci (Paris); 2007 Apr; 23(4):404-8. PubMed ID: 17433231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria for inclusion of vaccinations in public programmes.
    Houweling H; Verweij M; Ruitenberg EJ;
    Vaccine; 2010 Apr; 28(17):2924-31. PubMed ID: 20189486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children.
    Asturias EJ; Contreras-Roldan IL; Ram M; Garcia-Melgar AJ; Morales-Oquendo V; Hartman K; Rauscher M; Moulton LH; Halsey NA
    Vaccine; 2013 Dec; 31(49):5909-14. PubMed ID: 24055354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the effectiveness of the New Zealand meningococcal B vaccine.
    Kelly C; Arnold R; Galloway Y; O'Hallahan J
    Am J Epidemiol; 2007 Oct; 166(7):817-23. PubMed ID: 17615088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for the Expanded Programme on Immunization.
    Cutts FT; Waldman RJ; Zoffman HM
    Bull World Health Organ; 1993; 71(5):633-9. PubMed ID: 8261567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.